Viewing StudyNCT00461851



Ignite Creation Date: 2024-05-05 @ 5:30 PM
Last Modification Date: 2024-10-26 @ 9:32 AM
Study NCT ID: NCT00461851
Status: COMPLETED
Last Update Posted: 2017-12-14
First Post: 2007-04-16

Brief Title: Trial of Gemcitabine Carboplatin and Sorafenib in Chemotherapy-naive Patients With AdvancedMetastatic Bladder Carcinoma
Sponsor: Yale University
Organization: Yale University

Conditions & Keywords Data

Conditions:
Name
Bladder Cancer
Keywords:
Name View
AdvancedMetastatic Bladder Carcinoma View